PharmaNutra

PharmaNutra has over two decades of research in iron science with more than 150 clinical studies supporting its flagship SiderAL® line. Its proprietary Sucrosomial® Iron technology has demonstrated improved absorption and tolerability compared to traditional iron supplements. The company’s products are widely used across Europe and now also in the U.S., with millions of users worldwide.

The company’s pipeline focuses on innovative food supplements addressing key nutritional gaps as well as medical devices for musculoskeletal health.

Financially stable with consistent growth; recognized for scientific rigor and high-quality standards.